The bigger they are, the harder they fall - and the more notable their absence. First Data raised $2.6 billion in the year's largest IPO, but broke issue on the first day. Two small biotechs priced IPOs that were 1/100th the size of First Data's offering....read more
Strongbridge Biopharma, a late-stage biotech developing therapies for rare endocrine disorders, raised $25 million on Thursday by offering 2.5 million shares (80% insider) at $10. The Trevose, PA-company originally planned to offer 4.25 million shares at $17.93,...read more
Strongbridge Biopharma, a late-stage biotech developing therapies for rare endocrine disorders, slashed the proposed deal size for its upcoming IPO on Wednesday. It also removed lead left bookrunner BofA Merrill Lynch. The Trevose, PA-based company now...read more
Continuing the recent trend, four out of five deals priced below the range. This week, five companies raised $765 million, pricing an average of 19% below their proposed midpoints. All four deals that priced below traded up, popping 10% on...read more
US IPO Weekly Recap: Year's largest IPO First Data raises $2.6 billion and falls flat
The bigger they are, the harder they fall - and the more notable their absence. First Data raised $2.6 billion in the year's largest IPO, but broke issue on the first day. Two small biotechs priced IPOs that were 1/100th the size of First Data's offering....read more
Strongbridge Biopharma prices IPO at $10, as expected
Strongbridge Biopharma, a late-stage biotech developing therapies for rare endocrine disorders, raised $25 million on Thursday by offering 2.5 million shares (80% insider) at $10. The Trevose, PA-company originally planned to offer 4.25 million shares at $17.93,...read more
A bridge too far: Strongbridge Biopharma slashes IPO deal size by 67% to raise $25 million
Strongbridge Biopharma, a late-stage biotech developing therapies for rare endocrine disorders, slashed the proposed deal size for its upcoming IPO on Wednesday. It also removed lead left bookrunner BofA Merrill Lynch. The Trevose, PA-based company now...read more
US IPO Weekly Recap: Cut the offer price for positive returns
Continuing the recent trend, four out of five deals priced below the range. This week, five companies raised $765 million, pricing an average of 19% below their proposed midpoints. All four deals that priced below traded up, popping 10% on...read more